169 related articles for article (PubMed ID: 21387313)
1. Genetic variation in bone morphogenetic protein and colon and rectal cancer.
Slattery ML; Lundgreen A; Herrick JS; Kadlubar S; Caan BJ; Potter JD; Wolff RK
Int J Cancer; 2012 Feb; 130(3):653-64. PubMed ID: 21387313
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in the transforming growth factor-β signaling pathway and survival after diagnosis with colon and rectal cancer.
Slattery ML; Lundgreen A; Herrick JS; Wolff RK; Caan BJ
Cancer; 2011 Sep; 117(18):4175-83. PubMed ID: 21365634
[TBL] [Abstract][Full Text] [Related]
3. Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and riskof colon and rectal cancer: additional support for a TGF-β-signaling pathway.
Slattery ML; Lundgreen A; Herrick JS; Caan BJ; Potter JD; Wolff RK
Carcinogenesis; 2011 Mar; 32(3):318-26. PubMed ID: 21088106
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in the TGF-β signaling pathway and colon and rectal cancer risk.
Slattery ML; Herrick JS; Lundgreen A; Wolff RK
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):57-69. PubMed ID: 21068203
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.
Slattery ML; Herrick JS; Lundgreen A; Fitzpatrick FA; Curtin K; Wolff RK
Carcinogenesis; 2010 Sep; 31(9):1604-11. PubMed ID: 20622004
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation in the transforming growth factor-β-signaling pathway, lifestyle factors, and risk of colon or rectal cancer.
Slattery ML; Lundgreen A; Wolff RK; Herrick JS; Caan BJ
Dis Colon Rectum; 2012 May; 55(5):532-40. PubMed ID: 22513431
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in bone morphogenetic proteins and breast cancer risk in hispanic and non-hispanic white women: The breast cancer health disparities study.
Slattery ML; John EM; Torres-Mejia G; Herrick JS; Giuliano AR; Baumgartner KB; Hines LM; Wolff RK
Int J Cancer; 2013 Jun; 132(12):2928-39. PubMed ID: 23180569
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in RPS6KA1, RPS6KA2, RPS6KB1, RPS6KB2, and PDK1 and risk of colon or rectal cancer.
Slattery ML; Lundgreen A; Herrick JS; Wolff RK
Mutat Res; 2011 Jan; 706(1-2):13-20. PubMed ID: 21035469
[TBL] [Abstract][Full Text] [Related]
9. Variation in the CYP19A1 gene and risk of colon and rectal cancer.
Slattery ML; Lundgreen A; Herrick JS; Kadlubar S; Caan BJ; Potter JD; Wolff RK
Cancer Causes Control; 2011 Jul; 22(7):955-63. PubMed ID: 21479914
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor genes and their association with colon and rectal cancer development and prognosis.
Slattery ML; Herrick JS; Bondurant KL; Wolff RK
Int J Cancer; 2012 Jun; 130(12):2974-80. PubMed ID: 21792899
[TBL] [Abstract][Full Text] [Related]
11. Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival.
Slattery ML; Lundgreen A; Bondurant KL; Wolff RK
Carcinogenesis; 2011 Nov; 32(11):1660-7. PubMed ID: 21859832
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival.
Slattery ML; Curtin K; Poole EM; Duggan DJ; Samowitz WS; Peters U; Caan BJ; Potter JD; Ulrich CM
Int J Cancer; 2011 Jun; 128(11):2726-34. PubMed ID: 20949557
[TBL] [Abstract][Full Text] [Related]
13. PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States).
Slattery ML; Curtin K; Wolff R; Ma KN; Sweeney C; Murtaugh M; Potter JD; Levin TR; Samowitz W
Cancer Causes Control; 2006 Apr; 17(3):239-49. PubMed ID: 16489531
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in selenoprotein genes, lifestyle, and risk of colon and rectal cancer.
Slattery ML; Lundgreen A; Welbourn B; Corcoran C; Wolff RK
PLoS One; 2012; 7(5):e37312. PubMed ID: 22615972
[TBL] [Abstract][Full Text] [Related]
15. Energy balance, insulin-related genes and risk of colon and rectal cancer.
Slattery ML; Murtaugh M; Caan B; Ma KN; Neuhausen S; Samowitz W
Int J Cancer; 2005 May; 115(1):148-54. PubMed ID: 15688407
[TBL] [Abstract][Full Text] [Related]
16. MAP kinase genes and colon and rectal cancer.
Slattery ML; Lundgreen A; Wolff RK
Carcinogenesis; 2012 Dec; 33(12):2398-408. PubMed ID: 23027623
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants in the TGFβ-signaling pathway influence expression of miRNAs in colon and rectal normal mucosa and tumor tissue.
Slattery ML; Trivellas A; Pellatt AJ; Mullany LE; Stevens JR; Wolff RK; Herrick JS
Oncotarget; 2017 Mar; 8(10):16765-16783. PubMed ID: 28061442
[TBL] [Abstract][Full Text] [Related]
18. Interleukin genes and associations with colon and rectal cancer risk and overall survival.
Bondurant KL; Lundgreen A; Herrick JS; Kadlubar S; Wolff RK; Slattery ML
Int J Cancer; 2013 Feb; 132(4):905-15. PubMed ID: 22674296
[TBL] [Abstract][Full Text] [Related]
19. Statin Use After Diagnosis of Colon Cancer and Patient Survival.
Voorneveld PW; Reimers MS; Bastiaannet E; Jacobs RJ; van Eijk R; Zanders MMJ; Herings RMC; van Herk-Sukel MPP; Kodach LL; van Wezel T; Kuppen PJK; Morreau H; van de Velde CJH; Hardwick JCH; Liefers GJ
Gastroenterology; 2017 Aug; 153(2):470-479.e4. PubMed ID: 28512021
[TBL] [Abstract][Full Text] [Related]
20. TERT's role in colorectal carcinogenesis.
Pellatt AJ; Wolff RK; Herrick J; Lundgreen A; Slattery ML
Mol Carcinog; 2013 Jul; 52(7):507-13. PubMed ID: 22351525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
